FDA Inspection 1198356 — Sunrise Pharmaceutical, Inc.
The FDA completed an inspection of Sunrise Pharmaceutical, Inc. on January 27, 2023 in Rahway, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 27, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rahway, NJ (United States)